UniSa - IRIS Institutional Research Information System

TRIGGIANI, Massimo
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 8.164
AS - Asia 2.363
EU - Europa 2.158
SA - Sud America 498
AF - Africa 24
OC - Oceania 15
Continente sconosciuto - Info sul continente non disponibili 4
Totale 13.226
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 8.120
SG - Singapore 777
CN - Cina 633
UA - Ucraina 497
IT - Italia 475
BR - Brasile 425
RU - Federazione Russa 339
VN - Vietnam 333
DE - Germania 296
TR - Turchia 234
IE - Irlanda 209
KR - Corea 173
FI - Finlandia 119
HK - Hong Kong 110
SE - Svezia 77
AR - Argentina 45
GB - Regno Unito 42
AT - Austria 31
IN - India 28
CA - Canada 19
IQ - Iraq 13
MX - Messico 13
NL - Olanda 13
ES - Italia 11
CZ - Repubblica Ceca 10
ZA - Sudafrica 10
BD - Bangladesh 9
EC - Ecuador 9
NZ - Nuova Zelanda 9
FR - Francia 8
PK - Pakistan 8
AU - Australia 6
PL - Polonia 6
VE - Venezuela 6
AE - Emirati Arabi Uniti 5
JP - Giappone 5
UZ - Uzbekistan 5
CH - Svizzera 4
EU - Europa 4
JO - Giordania 4
MA - Marocco 4
PY - Paraguay 4
AM - Armenia 3
BE - Belgio 3
CO - Colombia 3
CR - Costa Rica 3
GR - Grecia 3
IL - Israele 3
KE - Kenya 3
MK - Macedonia 3
PE - Perù 3
PT - Portogallo 3
AZ - Azerbaigian 2
BN - Brunei Darussalam 2
BZ - Belize 2
DO - Repubblica Dominicana 2
EG - Egitto 2
KZ - Kazakistan 2
MD - Moldavia 2
MY - Malesia 2
NG - Nigeria 2
NI - Nicaragua 2
PA - Panama 2
SA - Arabia Saudita 2
UY - Uruguay 2
AL - Albania 1
BG - Bulgaria 1
CI - Costa d'Avorio 1
CL - Cile 1
ET - Etiopia 1
HR - Croazia 1
HU - Ungheria 1
IR - Iran 1
JM - Giamaica 1
KW - Kuwait 1
LB - Libano 1
LK - Sri Lanka 1
LT - Lituania 1
MM - Myanmar 1
NP - Nepal 1
OM - Oman 1
PS - Palestinian Territory 1
RO - Romania 1
SC - Seychelles 1
SI - Slovenia 1
SY - Repubblica araba siriana 1
TH - Thailandia 1
Totale 13.226
Salva come PNG Salva come JPEG
Città #
Ann Arbor 2.093
Woodbridge 1.132
Chandler 699
Jacksonville 661
Princeton 627
Houston 537
Wilmington 392
Dong Ket 326
Ashburn 278
Singapore 274
Izmir 222
Dublin 206
Andover 147
Nanjing 133
Boardman 113
Beijing 112
Hong Kong 110
Moscow 104
Pellezzano 103
Munich 73
Naples 57
Washington 55
Salerno 54
Nuremberg 53
The Dalles 51
Düsseldorf 50
Shenyang 49
Changsha 45
Fairfield 45
Hebei 42
Columbus 41
Norwalk 39
Jiaxing 38
Nanchang 37
Redwood City 37
Dallas 34
Buenos Aires 32
Los Angeles 30
Dearborn 27
São Paulo 27
Tianjin 25
Lappeenranta 22
Turku 19
Mestre 18
Rome 18
Milan 16
Seattle 16
Pune 15
Vienna 14
Council Bluffs 13
Belo Horizonte 12
New York 12
Rio de Janeiro 12
Cambridge 11
Chicago 11
Latina 10
London 10
Brooklyn 9
Falls Church 9
Jinan 9
Raleigh 9
Brno 8
Charlotte 8
San Diego 8
Santa Clara 8
Shanghai 8
Amsterdam 7
Curitiba 7
Guangzhou 7
Springfield 7
Istanbul 6
Phoenix 6
Salvador 6
Southampton 6
Volta Redonda 6
Warsaw 6
Auckland 5
Brasília 5
Florence 5
Montreal 5
Porto Alegre 5
Quito 5
Amman 4
Assago 4
Baghdad 4
Campinas 4
Fuzhou 4
Goiânia 4
Guarulhos 4
Hefei 4
Jinhua 4
Jundiaí 4
Mexico City 4
Pelotas 4
Piacenza 4
Piracicaba 4
San Jose 4
Stockholm 4
Tashkent 4
Teresina 4
Totale 9.681
Salva come PNG Salva come JPEG
Nome #
La triptasi sierica nella diagnosi di mastocitosi sistemica in pazienti adulti senza lesioni cutanee 186
A randomised, placebo-controlled, double blind phase III study of the efficacy and safety of recombinant human C1 inhibitor for the treatment of acute attacks in patients with hereditary angioedema 148
Antigen-induced generation of lyso-phospholipids in human airways. 141
Fragments of truth: T-cell targets of polyclonal immunoglobulins in autoimmune diseases 132
Current concepts on diagnosis and treatment of mastocytosis. 123
Allergia alimentare e probiotici: nuovi aspetti sulle interazioni tra il sistema immunitario ed i batteri commensali intestinali 119
Activation of human inflammatory cells by secreted phospholipases A2 118
Activation of human basophils by staphylococcal protein A. I. The role of cyclic AMP, arachidonic acid metabolites, microtubules and microfilaments. 116
Editorial overview: Immunomodulation: Modulation of the immune system: Per aspera ad astra 115
Arachidonic acid metabolism during antigen and ionophore activation of the mouse bone marrow derived mast cell. 112
Anaphylaxis and cardiovascular diseases 112
Biochemical functions of a pool of arachidonic acid associated with triglycerides in human inflammatory cells. 110
Antileucotrieni nell'asma bronchiale: bilancio e prospettive 110
L'acido ialuronico nella regolazione delle risposte infiammatorie ed immunologiche 109
Activation of cytokine production by secreted phospholipase A2 in human lung macrophages expressing the M-type receptor 109
Assay of antibody to group A streptococcal carbohydrate by enzyme-linked immunosorbent assay. 108
Human Macrophages and Monocytes Express Functional Na+/Ca2+ Exchangers 1 and 3Sodium Calcium Exchange: A Growing Spectrum of Pathophysiological Implications 107
MACVIA clinical decision algorithm in adolescents and adults with allergic rhinitis 107
ARIA 2016: Care pathways implementing emerging technologies for predictive medicine in rhinitis and asthma across the life cycle 107
KIT mutation analysis in mast cell neoplasms: recommendations of the European Competence Network on Mastocytosis 102
Molecular diagnosis and the Italian Board for ISAC. 100
Are mast cells MASTers in HIV-1 infection? 99
Advances in the classification and treatment of mastocytosis: Current status and outlook toward the future 99
Efficacy and safety of recombinant human C1-inhibitor for the treatment of attacks of hereditary angioedema: European open-label extension study 97
Triggers and prodromal symptoms of angioedema attacks in patients with hereditary angioedema 97
Relative amounts of 1-O-alkyl- and 1-acyl-2-acetyl-sn-glycero-3-phosphocholine in stimulated endothelial cells. 96
Biological effects of 1-acyl-2-acetyl-sn-glycero-3-phosphocholine in the human neutrophil. 96
Classification, diagnosis, and approach to treatment for angioedema: consensus report from the Hereditary Angioedema International Working Group 95
Refined diagnostic criteria and classification of mast cell leukemia (MCL) and myelomastocytic leukemia (MML): a consensus proposal 94
A nationwide survey of hereditary angioedema due to C1 inhibitor deficiency in Italy 93
Expression and function of angiopoietins and their tie receptors in human basophils and mast cells 92
A unique case of angioedema with anti-C1 inhibitor antibodies and normal C1 inhibitor levels 92
Pharmacological modulation of human mast cells and basophils 92
Secretory phospholipases A2 in inflammatory and allergic diseases: not just enzymes. 90
Diagnostic and therapeutic management of hereditary angioedema due to C1-inhibitor deficiency: The Italian experience 90
Sensitization to Common and Uncommon Pets or Other Furry Animals: Which May Be Common Mechanisms? 90
Elevated plasma levels of vascular permeability factors in C1 inhibitor-deficient hereditary angioedema 90
Home Therapy with Plasma-Derived C1 Inhibitor: A Strategy to Improve Clinical Outcomes and Costs in Hereditary Angioedema 89
Short-term and long-term role of platelet activating factor as a mediator of in vivo platelet aggregation. 88
Inhibition of IgE-mediated release of histamine and peptide leukotriene from human basophils and mast cells by forskolin. 87
Research needs in allergy: an EAACI position paper, in collaboration with EFA 87
What we should learn from the London Olympics 87
Biomarkers of the involvement of mast cells, basophils and eosinophils in asthma and allergic diseases 87
Molecular and cellular biology of mast cells and basophils. 86
Inhibition of histamine and prostaglandin D2 release from human lung mast cells by ciclosporin A. 86
Component resolved diagnosis (CRD): how much is it presently used by Italian allergists? 86
Proposed diagnostic algorithm for patients with suspected mastocytosis: a proposal of the European Competence Network on Mastocytosis 86
A review of hereditary angioedema and recombinant human C1-inhibitor treatment 86
Benzene metabolites inhibit the release of proinflammatory mediators and cytokines from human basophils 86
Metabolism of platelet-activating factor in the guinea-pig heart. 85
Factors that influence the proportions of platelet-activating factor and 1-acyl-2-acetyl-sn-glycero-3-phosphocholine synthesized by the mast cell. 85
Control of arachidonate levels within inflammatory cells. 85
360 degree perspective on allergic rhinitis management in Italy: A survey of GPs, pharmacists and patients 85
Role of human mast cells and basophils in bronchial asthma. 84
Stress and Psychological Factors in the Variable Clinical Phenotype of Hereditary Angioedema in Children: A Pilot Study 84
Role of human FcεRI+ cells in HIV-1 infection 84
Evidence that increasing the cellular content of eicosapentaenoic acid does not reduce the biosynthesis of platelet-activating factor. 83
Mutational Spectrum of the C1 Inhibitor Gene in a Cohort of Italian Patients with Hereditary Angioedema: Description of Nine Novel Mutations 83
Management of chronic spontaneous urticaria: practical parameters 83
Simplexide Induces CD1d-Dependent Cytokine and Chemokine Production from Human Monocytes 82
Studi tossicologici sugli effetti dell'idrochinone e del benzochinone sui basofili umani 82
European Competence Network on Mastocytosis (ECNM): 10-year jubilee, update, and future perspectives 82
Mastocytosis presenting as cardiac emergency 82
Influence of immunologic activation and cellular fatty acid levels on the catabolism of platelet-activating factor within the murine mast cell (PT-18). 81
Oxygen radicals inhibit human plasma acetylhydrolase, the enzyme that catabolizes platelet-activating factor. 81
Inhibition of IgE-mediated histamine release from human basophils and mast cells by fenoterol. 81
Phenotypical and functional heterogeneity of human lung macrophages 81
Evaluation of vaccination safety in children with mastocytosis 81
HIV-1 envelope gp41 peptides promote migration of human FcεRI+ cells and inhibit IL-13 synthesis through interaction with formyl peptide receptors 81
A Survey of Clinical Features of Allergic Rhinitis in Adults 80
Oxidative stress markers are increased in patients with mastocytosis 80
Cyclosporin A rapidly inhibits mediator release from human basophils presumably by interacting with cyclophilin. 80
AIRWAYS-ICPs (European Innovation Partnership on Active and Healthy Ageing) from concept to implementation 80
Biomarkers for evaluation of mast cell and basophil activation 80
Non lymphomatous clonal B-Cell populations in enlarged lymph nodes in acquired immunodeficiency syndrome. 80
Migration of human inflammatory cells into the lung results in the remodeling of arachidonic acid into a triglyceride pool. 79
Metabolism of lipid mediators in human basophils and mast cells. 79
Mast cells as effector cells of innate immunity and regulators of adaptive immunity 79
Perioperative anaphylactic risk score for risk-oriented premedication. 78
Chemical mediators and the human heart. 77
Synthesis of 1-acyl-2-acetyl-sn-glycero-3-phosphocholine by an enriched preparation of the human lung mast cell. 77
Dietary n-3 fatty acid effects on neutrophil lipid composition and mediator production. Influence of duration and dosage. 77
Differential roles for triglyceride and phospholipid pools of arachidonic acid in human lung macrophages. 77
Potential benefit of omalizumab in respiratory diseases 77
Inhibition of secretory phospholipase A2-induced cytokine production in human lung macrophages by budesonide 77
Recent advances in our understanding of the biochemical interactions between platelet-activating factor and arachidonic acid. 76
Arachidonic acid remodeling in human inflammatory cells migrating to the lung in vivo. 76
Cutaneous manifestations in patients with mastocytosis: Consensus report of the European Competence Network on Mastocytosis; The American Academy of Allergy, Asthma & Immunology; And the European Academy of Allergology and Clinical Immunology 75
Enhanced Expression of CD47 Is Associated With Off-Target Resistance to Tyrosine Kinase Inhibitor Gefitinib in NSCLC 75
Heterogeneity of human mast cells and basophils. Effects of a putative 5-lipoxygenase inhibitor. 74
Characterization of platelet-activating factor acetylhydrolase in human bronchoalveolar lavage. 74
Human mast cells and basophils in HIV-1 infection 73
Mast cells, basophils and their mediators 72
Integrated care pathways for airway diseases (AIRWAYS-ICPs) 72
Immunopharmacological modulation of mast cells 72
Metabolism of 1-acyl-2-acetyl-sn-glycero-3-phosphocholine in the human neutrophil. 71
Differential synthesis of 1-acyl-2-acetyl-sn-glycero-3-phosphocholine and platelet-activating factor by human inflammatory cells. 71
Basophil count in neonates is not suitable for atopy predictivity. 71
The additional values of microarray allergen assay in the management of polysensitized patients with respiratory allergy 71
Effect of activation of the H1 receptor on coronary hemodynamics in man. 70
Totale 9.039
Salva come PNG Salva come JPEG
Categoria #
all - tutte 52.158
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 52.158
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.133 21 82 95 12 151 46 150 22 91 11 99 353
2021/20221.047 9 3 4 18 10 19 9 44 166 139 137 489
2022/20231.740 184 104 59 200 244 388 12 165 260 6 93 25
2023/20241.002 82 110 122 49 97 174 23 44 11 40 47 203
2024/20252.428 79 34 33 96 109 283 353 246 465 199 281 250
2025/2026132 132 0 0 0 0 0 0 0 0 0 0 0
Totale 13.530